Stocks making the biggest moves midday: Nucor, Sunrun, Affirm, Zoetis, Circle and more
Check out the companies making headlines in midday trading. Steel stocks– Shares of steel producer Nucor jumped more than 3%. The company issued rosy guidance for its second-quarter earnings, calling for $2.55 to $2.65 per share, while FactSet consensus estimates sought $2.36 per share. In contrast, Steel Dynamics' guidance fell short of Wall Street's estimates, ranging from $2.00 to $2.04 per share, while analysts were looking for $2.73 per share. The stock slipped 1%. The moves follow the completion of the Nippon Steel-U.S. Steel deal . Shares of peer companies Cleveland-Cliffs and Reliance were little changed. Scholar Rock Holding — Shares jumped nearly 15% after the biotech reported its experimental drug showed it was able to help patients taking Eli Lilly 's obesity drug lose less muscle as they shed pounds. Lilly shares were down slightly. Affirm — The consumer finance stock rose 3% after Affirm announced the creation a new loan sale facility with Prudential's PGIM Fixed Income business. Prudential will buy as much as $500 million of Affirm's consumer loans at any one time, with a total investment of $3 billion over the next three years. Sunrun — Shares of the solar company rose 5% despite a downgrade to sector perform from outperform by RBC Capital Markets. The stock on Tuesday recorded its biggest one-day loss in its history amid a sell-off in solar names. Other solar stocks including Enphase Energy , which was up nearly 5%, and Solaredge , which gained 7%, were also higher. Bausch Health — Shares climbed 8% after John Paulson, its nonexecutive chair, acquired 3.6 million shares of the pharma company's stock. The purchase came on the heels of a $14.7 million purchase disclosed last week. Paulson now owns about 9% of the company's outstanding stock. CERo Therapeutics Holdings — Stock in the immunotherapy company pulled back more than 30%. On Tuesday, the U.S. Food and Drug Administration gave the company's acute myeloid leukemia drug CER-1236 an orphan drug designation . Shares rose more than 188% on that news. Chemours — The chemical stock rose 8% after an updated second-quarter forecast showed weakness in a key profit metric. Chemours said it expects consolidated adjusted EBITDA — or earnings before interest, taxes, depreciation and amortization — of $215 million to $225 million for the period. Wall Street expectations called for $236 million, according to FactSet. Regencell Bioscience — Shares dropped 26% after an eyewatering move higher this week . The Hong Kong-based developer of traditional Chinese herbal treatments has said it can treat childhood ADHD and autism. Regencell jumped 30% on Tuesday, and soared 283% Monday, following a 38-for-1 stock split. It's gained more than 59,000% this year. Oracle — The software company gained more than 1% after Guggenheim raised its price target on the stock to the highest on the Street. Analyst John DiFucci said Oracle is "on the precipice of a narrative shift that has been decades of technology innovation in the making." Zoetis — Shares of the animal health company slipped 3% following a downgrade at Stifel to hold from buy. The firm said it expects Zoetis' revenue growth to decelerate further amid increasing competition. Korn Ferry — Shares of the consulting firm gained 9% after fourth-quarter results surpassed analyst estimates on the top and bottom line. Korn Ferry earned $1.32 per share, excluding items, on revenue of $712 million. Analysts polled by FactSet expected a profit of $1.26 per share and revenue of $689.9 million. Circle Internet Group — Stock in the company behind stablecoin USDC advanced almost 16%, after the U.S. Senate passed the GENIUS bill . The legislation is the first of its kind and establishes federal guidelines for digital dollars that are pegged to the greenback. — CNBC's Brian Evans, Sarah Min, Michelle Fox, Alex Harring, Fred Imbert, Yun Li, Jesse Pound and Darla Mercado contributed reporting.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
15 minutes ago
- CBS News
San Jose Earthquakes owner John Fisher puts team on the market
The owner of the San Jose Earthquakes announced Wednesday that he has begun the process of selling the Major League Soccer club. John Fisher, who also owns baseball's Athletics, acquired the Earthquakes with Lew Wolff in 2007 for a $20 million expansion fee, bringing the team back in 2008 after a two-year hiatus. "The San Jose Earthquakes and PayPal Park have been an important part of our lives for nearly two decades," Fisher said in a statement released by the team. "We are proud of the role the Quakes have played in the growth of soccer throughout Silicon Valley. The Bay Area is a special place, and we're deeply grateful to the fans, players and staff who've been with us on this journey." The Earthquakes have hired the New York-based investment firm Moelis & Co. to lead the sale. The Earthquakes, then known as the San Jose Clash, were a founding member of MLS in 1996. The team won MLS Cup titles in 2001 and 2003. The Quakes also own and operate PayPal Park, an 18,000-seat stadium which is also the home of the National Women's Soccer League team Bay FC. "On behalf of Major League Soccer, I want to thank the Fisher family for their longstanding commitment to the Earthquakes and the San Jose community," MLS Commissioner Don Garber said in a statement. "Under their leadership, the club invested in world-class facilities like PayPal Park, built a highly respected youth academy and helped grow the game in one of the nation's most dynamic markets." The Quakes are the second MLS franchise currently up for sale. The Vancouver Whitecaps are the other.
Yahoo
20 minutes ago
- Yahoo
Partners Group buys UK pet-food business MPM from 3i
Partners Group has agreed to buy UK pet-food business MPM Products from its UK private-equity peer 3i. Established 2002, Manchester-based MPM's portfolio includes cat-focused brands such as Applaws, Reveal and Encore. With offices in the UK, Australia, China and US, MPM sells its products in 49 markets globally, according to the company's official Linkedin account. In a statement, 3i said MPM's sales and EBITDA have more than 'doubled' since its investment in 2020, though specific figures were not disclosed. International sales now account for nearly 80% of MPM's revenues across the US, EMEA, and APAC regions, the private-equity firm said. 3i said the "total gross proceeds" to the buy-out house are estimated at approximately £400m ($538.2m). In a separate statement, Partners Group said the cat-food sector is "benefitting from several thematic tailwinds". People are delaying having babies, leading to increased pet ownership and the "premiumisation" of purchases. Thomas Clark, MD for private-equity goods and products at Partners Group, said: "We have been tracking the pet food market as part of our broader thematic research into the 'humanisation' of pets. We believe there is a significant growth opportunity in the premium cat food segment as this has historically been underserved by incumbent producers that are primarily 'dog focused'." The transaction is subject to customary regulatory approvals and is expected to be completed in the third quarter of the year. Julian Bambridge, MPM's CEO, said: "Feeding is one of the key moments when owners interact with their cats, which reinforces a desire to provide something special at these times. At MPM, our goal is to enrich the lives of pets and owners through visibly better food that uses the highest quality natural ingredients and provides core health benefits. We are excited to continue our strong growth under Partners Group's ownership." "Partners Group buys UK pet-food business MPM from 3i" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
20 minutes ago
- Yahoo
‘Big Short' investor warns the precarious tariff environment reminds him of WWI—and a trade war would send the U.S. into a recession
Should failed tariff negotiations lead to a trade war, the global economy is likely headed toward a recession, The Big Short investor Steve Eisman told CNBC this week. Eisman said the tariffs were the 'only real risk' to the markets and warned the U.S. should be especially concerned with negotiating with the European Union ahead of the approaching July 9 trade-deal deadline. Global markets will enter dire economic straits if President Donald Trump's ongoing tariff stance leads to an all-out trade war, warns billionaire investor Steve Eisman. The former managing director of Neuberger Berman—who successfully anticipated and profited from the 2008 stock market crash, and whose profile served as the basis for Michael Lewis' book (and later, the 2015 film) The Big Short—said in a CNBC interview on Tuesday the U.S. economy and markets will flourish if the Trump administration is able to facilitate truces with the various nations on which he has imposed tariffs. But if that doesn't happen, 'chances are, we go into a global recession.' 'The tariffs and the potential for a trade war, I think, is really the only risk to the market right now,' Eisman said. 'It's completely binary, and I really have no way of handicapping it.' Trump's whipsaw tariff decisions have rattled both consumers—who have sharply cut back on spending as a result of the levies—and investors, who, like Eisman, see tariffs as a threat to the global economy. A Bank of America Global Fund Manager Survey published this week found 47% of the 222 fund managers surveyed said they believed a global recession as a result of a trade war was the biggest 'tail risk' to markets. Trade deals, such as with the UK and a tentative truce with China, have tempered these concerns. JPMorgan Research lowered its probability of U.S. and global recessions from 60% to 40% at the end of May, citing decreased trade tensions as a result of Trump slashing Chinese tariffs. The U.S., however, has yet to resolve its trade issues with the European Union ahead of a crucial July 9 deadline. Eisman drew similarities between the rocky trade environment and lead-up to World War I, likely referring to a series of treaties forged in the decades before the war designed to settle regional skirmishes that, in reality, created two massive, and eventually opposing, alliances. 'Nobody wanted World War I, and yet, because of all the reciprocal treaties that existed between countries, they somehow ended up there,' he said. 'I don't think anybody wants a trade war, but it's certainly possible.' Though trade talks with China have taken center stage, Eisman argued the process of solidifying trade relations with Europe is 'more interesting,' given the EU's concerns with regulations, as well as value-added tax (VAT). With 27 member states, the EU has to balance myriad agendas, complicating a potential trade deal. 'Negotiating with Europe is like trying to herd cats given the way they're structured,' Eisman said. Trump has claimed the EU was created to 'screw' the U.S., threatening to impose, then later pausing, a 50% tariff on the union. As part of negotiations, the administration has tried to pressure the EU to loosen tech regulations he claims are inhibiting growth of U.S. companies. Trump also opposes VAT, essentially a sales tax that accumulates through each stage in a product's supply chain. The president has interpreted VAT as another trade barrier, arguing the tax puts undue financial pressure on U.S. businesses trying to export to Europe. Trump has signaled that the U.S. is not yet satisfied with provisions of the agreement, telling reporters on Tuesday, 'We're talking, but I don't feel that they're offering a fair deal yet.' Trump's former commerce secretary Wilbur Ross warned that after successful negotiations with China and the U.K., the Trump administration may become overconfident in negotiations with the EU, pushing away European allies. 'One fear is that if our government feels too chesty with their progress, they may overplay the hand and get to levels that are hard—maybe even impossible—for the other countries to give in,' Ross told Fortune last week. 'This is going to be hard, but our country's goal should be to help make European nations stronger and keep them close,' he added. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
